Dr. Ralph de la Torre is the Founder, Chairman and Chief Executive Officer of Steward Health Care System LLC. Steward is an innovative health care provider which combines 3,000 physicians, 10 hospital campuses, managed care, insurance programs, home care and a number of other post-acute services to provide the most cost effective and highest quality of integrated patient care. Founded in 2010, Steward has grown to $2.4 billion in net patient service revenues (non-premium), is the fourth largest employer in Massachusetts, and is New England’s largest community care company. Today, Steward is widely recognized as a national leader in implementing a new model of integrated health care delivery.
Prior to Steward, Dr. de la Torre was the CEO of Caritas Christi Health Care, where he led the dramatic transformation of a six hospital system, restoring it to profitability while simultaneously improving the quality of patient care. Before joining Caritas Christi, Dr. de la Torre was the founder and CEO of the Cardiovascular Institute at Beth Israel Deaconess Medical Center (BIDMC) and Chief of Cardiac Surgery as well as for the Harvard Medical Faculty Physicians at BIDMC, where he was widely recognized as one of the top cardiac surgeons in his field. Prior to his career as a cardiac surgeon, Dr. de la Torre founded several biotech businesses. Notable board assignments for Dr. de la Torre include Member, Board of Trustees of Boston College, Member, Board of Directors and Executive Committee Member of the Boston Ballet, Board of Directors of the Federation of American Hospitals and the United States Chamber of Commerce Board of Directors. A frequent commentator on national health care policy issues, Dr. de la Torre has bylined and/or been featured in BusinessWeek, Fortune and CNBC, among others. He was recently voted one of the 25 most powerful physician executives in the United States by Modern Healthcare magazine. Dr. de la Torre graduated from Duke University in 1988 (BSE), where he was a member of Phi Beta Kappa and Tau Beta Pi, and from a joint program between Harvard Medical School (MD) and the Massachusetts Institute of Technology (MS) in 1992.